FDA Unapproved Drugs: The $7.5 Billion 505(b)(2) Opportunity Most Pharma Execs Are Ignoring
The Anomaly That Keeps Paying Here is a fact that surprises most people who work outside drug regulatory affairs: hundreds […]
December 2017
Global Pharmaceutical Export Expansion: The Definitive Playbook for IP-Led Market Leadership
Section 1: The Global Pharmaceutical Trade Architecture: Flow Mapping, Hub Dynamics, and Value Chain Positioning The global pharmaceutical export market
Drug Patent Fortress Strategy: The Playbook for Pharma IP Teams
I. Executive Summary The pharmaceutical patent fortress is no longer just a legal concept. It is the primary financial architecture
Drug Patent Fortress Strategy: The Playbook for Pharma IP Teams Read Post »
Generic Drug Development: The Complete IP, Regulatory, and Portfolio Strategy Guide
1. The Market in Numbers: What the Patent Cliff Actually Means for Generic Opportunity Scale, Growth, and the Savings Paradox
Generic Drug Development: The Complete IP, Regulatory, and Portfolio Strategy Guide Read Post »
